Page last updated: 2024-11-05

diborane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

diborane: reduces heterocyclic cpds [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

diborane : Boranes containing only two B atoms, linked either directly by a B-B bond or via hydrogen bridging atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12544637
MeSH IDM0083257

Synonyms (8)

Synonym
19287-45-7
diboron hexahydride
diborane(6)
diborane
borane (b2h6)
hydrogen boride (h6b2)
boron hydride (b2h6)
diborane (b2h6)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Changes in bronchoalveolar lavage fluid (BALF) and blood were examined to assess the toxic effects of diborane (B2H6, CAS: 19287-45-7) on the lung."( Inhalation toxicity of diborane in rats assessed by bronchoalveolar lavage examination.
Nomiyama, T, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (36.67)18.7374
1990's7 (23.33)18.2507
2000's8 (26.67)29.6817
2010's4 (13.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.23%)5.53%
Reviews1 (3.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (93.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]